Pfizer and BioNTech launch study of Covid-19 vaccine in healthy pregnant women
The study will evaluate the safety and efficacy of the vaccine given to pregnant women during weeks 24-34 of gestation, with the two doses given 21 days apart. The trial will also assess whether vaccinated women transfer protective antibodies to their babies.
Source:
Reuters Health